BMI |
body mass index |
PHC |
perihilar cholangiocarcinoma |
HPB |
hepato-pancreato-biliary |
WHO |
World Health Organization |
RFS |
recurrence-free survival |
EU |
European region |
AJCC |
American Joint Committee on Cancer |
UICC |
International Union Against Cancer |
CT |
computed tomography |
MRI |
magnetic resonance imaging |
MRCP |
magnetic resonance cholangiopancreatography |
EBD |
endoscopic biliary drainage |
PTBD |
percutaneous transhepatic biliary drainage |
PVE |
portal vein embolization |
CLR |
caudate lobe resection |
CEA |
carcinoembryonic antigen |
CA 19-9 |
cancer antigen 19-9 |
ASA |
American society of anesthesiologists |
TNM |
tumor node metastasis |
ANOVA |
analysis of variance |
RI |
recurrence interval |
RFS |
recurrence free survival |
HR |
hazard ratio |
CI |
confidence interval |
HCC |
hepatocellular carcinoma |
iCCA |
intrahepatic cholangiocarcinoma |
NASH |
non-alcoholic steatohepatitis |
NAFLD |
non-alcoholic fatty liver disease |
eCCA |
extrahepatic cholangiocarcinoma |